
|Articles|July 1, 2003
Tailoring Tx to Disease Stage
San Francisco - When treating cutaneous T-cell lymphoma (CTCL), dermatologists will want to tailor their treatment to the stage of the disease, according to Madeleine Duvic, M.D., who spoke at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














